Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
Holders of 5% or more of TIL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Instil Bio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 13G/A | 6.70%440.0K shares | – | Feb 13, 20251 filing | Feb 13, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Instil Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 20258:51 PM ET | Vivo Capital IX, LLCand 1 other | 13G/A | 4.50%292.7K shares | –Below 5% | Jun 30, 2025 | SEC |
| May 15, 20257:34 PM ET | Boxer Capital Management, LLCand 5 others | 13G/A | 1.20%80.1K shares | –Below 5% | May 9, 2025 | SEC |
| May 15, 20254:30 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2025 | SEC |
| Feb 13, 20254:14 PM ET | BML Investment Partners, L.P.and 1 other | 13G/A | 6.70%440.0K shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Instil Bio, Inc. shares.
No Form 144 notices for Instil Bio, Inc. are on file.